SPHK2 and colorectal cancer: For example, hsa-miR-363-3p was found to inhibit tumor growth and metastasis of colorectal cancer via targeting SPHK2 [34]; He et al. suggested that hsa-miR-363-3p acted as a tumor suppressor in osteosarcoma cells by inhibiting PDZD2 [35].